Oscar Health, Inc.
OSCR
$17.11
$0.050.29%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 27.40% | -1.28% | |||
| Total Other Revenue | -10.02% | -1.78% | |||
| Total Revenue | 27.33% | -1.28% | |||
| Cost of Revenue | 9.42% | 3.05% | |||
| Gross Profit | 140.32% | -21.97% | |||
| SG&A Expenses | 3.64% | 1.18% | |||
| Depreciation & Amortization | -27.11% | 23.11% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.23% | 2.76% | |||
| Operating Income | 301.12% | -205.39% | |||
| Income Before Tax | 287.53% | -193.79% | |||
| Income Tax Expenses | 3,244.80% | -119.46% | |||
| Earnings from Continuing Operations | 279.73% | -181.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 10.31% | -25.96% | |||
| Net Income | 279.27% | -181.24% | |||
| EBIT | 301.12% | -205.39% | |||
| EBITDA | 319.39% | -238.84% | |||
| EPS Basic | 277.09% | -175.42% | |||
| Normalized Basic EPS | 284.51% | -186.77% | |||
| EPS Diluted | 234.11% | -204.67% | |||
| Normalized Diluted EPS | 251.55% | -186.77% | |||
| Average Basic Shares Outstanding | 1.24% | 2.10% | |||
| Average Diluted Shares Outstanding | 23.26% | 2.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||